Why The CDC & FDA Are Pausing Johnson & Johnson Vaccine Distribution

The Food and Drug Administration (FDA) and Centers for Disease Control & Prevention (CDC) announced early Tuesday that they recommended pausing use of the Johnson & Johnson (Janssen) single-dose coronavirus vaccine (which has been given to more than 6.8 million people in the United States as of April 12) out of an abundance of caution due to six women between the ages of 18 and 48 developing a rare type of blood clot, according to a joint statement from the agencies. Per The New York Times, one woman died due to a blood clot and another was hospitalized.

Related story

I Wish I Were Fighting With My Teen About Sex & Drugs This Year, Not Zoom